Skip to content
B
Biotech
Edge
New: AI Alerts
Catalysts
Convergence
Squeeze
Signals
Cash Runway
Insiders
M&A
Research
Sign In
Start 14-Day Free Trial
Home
›
M&A Tracker
›
CERE + AbbVie
Cerevel Therapeutics
+ AbbVie
closed
$CERE acquired by AbbVie for $8.7B
← All biotech acquisitions